Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2011

01-06-2011 | Research Article

Effects of an operational multidisciplinary team on hospital antibiotic use and cost in France: a cluster controlled trial

Authors: Sibylle Bevilacqua, Béatrice Demoré, Marie-Line Erpelding, Emmanuelle Boschetti, Thierry May, Isabelle May, Christian Rabaud, Nathalie Thilly

Published in: International Journal of Clinical Pharmacy | Issue 3/2011

Login to get access

Abstract

Objective The study objective was to evaluate the effectiveness of an operational multidisciplinary antibiotic team, including an infectious disease physician and a clinical pharmacist, in reducing the hospital antimicrobial consumption and costs. Setting The 1800-bed University Hospitals of Nancy (France). Method A cluster controlled ‘before-after’ study was performed. The intervention group comprised 11 medical and surgical wards in settings where the operational antibiotic team was implemented, and the control group comprised 6 wards without this operational team. The ‘before’ period (2005) preceded the implementation of the operational team in the intervention group and ‘after’ (July 2007 to June 2008) followed its full implementation. Main outcome measure We compared consumption of antibiotics overall and by therapeutic class (in defined daily doses per 1,000 patient days) and cost savings (in €) between ‘before’ and ‘after’ in both groups (control and intervention), using a mixed effect linear model. Results The overall consumption of antibiotics decreased after implementation of the operational team by 33.6% in the intervention group and by 3.3% in the control group (P = 0.003). Compared with the control group, the decrease in antibiotic use in the intervention group was significantly higher for various therapeutic classes (broad-spectrum penicillins, injectable fluoroquinolones, glycopeptides) and specific drugs (imipenem, ciprofloxacin, teicoplanin). For the same activity, the total cost savings were 14-fold higher in the intervention group. Conclusion Establishment of an operational multidisciplinary team may be an effective way to reduce hospital antibiotic use and cost, with a good acceptance rate among prescribers.
Literature
1.
go back to reference Guillemot D, Maison P, Carbon C, Balkau B, Vauzelle-Kervroëdan F, Sermet C, et al. Trends in antimicrobial use in the community–France, 1981–1992. J Infect Dis. 1998;177(2):492–7.PubMedCrossRef Guillemot D, Maison P, Carbon C, Balkau B, Vauzelle-Kervroëdan F, Sermet C, et al. Trends in antimicrobial use in the community–France, 1981–1992. J Infect Dis. 1998;177(2):492–7.PubMedCrossRef
2.
go back to reference Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Projet ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis. 1999;29(2):245–52.PubMedCrossRef Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Projet ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis. 1999;29(2):245–52.PubMedCrossRef
3.
go back to reference Borg MA, Zarb P, Ferech M, Goossens H. Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project. J Antimicrob Chemother. 2008;62(4):830–6.PubMedCrossRef Borg MA, Zarb P, Ferech M, Goossens H. Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project. J Antimicrob Chemother. 2008;62(4):830–6.PubMedCrossRef
4.
go back to reference Day D, Lubowski TJ, Yamaga CC, Main J, Van Vleet J, Ambegaonkar A. Computer-assisted evaluation of antibiotic regimen coverage and cost. Clin Ther. 1999;21(8):1418–25.PubMedCrossRef Day D, Lubowski TJ, Yamaga CC, Main J, Van Vleet J, Ambegaonkar A. Computer-assisted evaluation of antibiotic regimen coverage and cost. Clin Ther. 1999;21(8):1418–25.PubMedCrossRef
5.
go back to reference Dunagan WC, Woodward RS, Medoff G, Gray JL III, Casabar E, Smith MD, et al. Antimicrobial misuse in patients with positive blood cultures. Am J Med. 1989;87(3):253–9.PubMedCrossRef Dunagan WC, Woodward RS, Medoff G, Gray JL III, Casabar E, Smith MD, et al. Antimicrobial misuse in patients with positive blood cultures. Am J Med. 1989;87(3):253–9.PubMedCrossRef
6.
go back to reference Denton M, Morgan MS, White RR. Quality of prescribing of intravenous antibiotics in a district general hospital. BMJ. 1991;302(6772):327–8.PubMedCrossRef Denton M, Morgan MS, White RR. Quality of prescribing of intravenous antibiotics in a district general hospital. BMJ. 1991;302(6772):327–8.PubMedCrossRef
7.
go back to reference Barenfanger J, Short MA, Groesh AA. Improved antimicrobial interventions have benefits. J Clin Microbiol. 2001;39(8):2823–8.PubMedCrossRef Barenfanger J, Short MA, Groesh AA. Improved antimicrobial interventions have benefits. J Clin Microbiol. 2001;39(8):2823–8.PubMedCrossRef
8.
go back to reference Bantar C, Sartori B, Vesco E, Heft C, Saùl M, Salamone F, et al. A hospital wide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis. 2003;37(2):180–6.PubMedCrossRef Bantar C, Sartori B, Vesco E, Heft C, Saùl M, Salamone F, et al. A hospital wide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis. 2003;37(2):180–6.PubMedCrossRef
9.
go back to reference Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious diseases Society of America. J Infect Dis. 1988;157(5):869–76.PubMedCrossRef Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious diseases Society of America. J Infect Dis. 1988;157(5):869–76.PubMedCrossRef
10.
go back to reference Ministry of Health and Ministry of Food, Agriculture and Fisheries, Denmark. Report from the European Union Conference on ‘The Microbial Threat’, Copenhagen Recommendations. Copenhagen, Denmark; 9–10 September 1998. Ministry of Health and Ministry of Food, Agriculture and Fisheries, Denmark. Report from the European Union Conference on ‘The Microbial Threat’, Copenhagen Recommendations. Copenhagen, Denmark; 9–10 September 1998.
12.
go back to reference Arrêté du 31 mars 1999 relatif à la prescription, à la dispensation et à l’administration des médicaments soumis à la réglementation des substances vénéneuses dans les établissements de santé, les syndicats interhospitaliers et les établissements médico-sociaux disposant d’une pharmacie à usage intérieur mentionnés à l’article L. 595-1 du code de la santé publique. Arrêté du 31 mars 1999 relatif à la prescription, à la dispensation et à l’administration des médicaments soumis à la réglementation des substances vénéneuses dans les établissements de santé, les syndicats interhospitaliers et les établissements médico-sociaux disposant d’une pharmacie à usage intérieur mentionnés à l’article L. 595-1 du code de la santé publique.
13.
go back to reference Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborative Center for Drug Statistics Methodology, Norwegian Institute of Public Health; 2007. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborative Center for Drug Statistics Methodology, Norwegian Institute of Public Health; 2007.
14.
go back to reference Gums JG, Yancey RW Jr, Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy. 1999;19(12):1369–77.PubMedCrossRef Gums JG, Yancey RW Jr, Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy. 1999;19(12):1369–77.PubMedCrossRef
15.
go back to reference Scheetz MH, Bolon MK, Postelnick M, Noskin GA, Lee TA. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. J Antimicrob Chemother. 2009;63(4):816–25.PubMedCrossRef Scheetz MH, Bolon MK, Postelnick M, Noskin GA, Lee TA. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. J Antimicrob Chemother. 2009;63(4):816–25.PubMedCrossRef
16.
go back to reference Von Gunten V, Troillet N, Beney J, Boubaker K, Lüthi JC, Taffé P, et al. Impact of an interdisciplinary strategy on antibiotic use: a prospective controlled study in three hospitals. J Antimicrobial Chemother. 2005;55(3):362–6.CrossRef Von Gunten V, Troillet N, Beney J, Boubaker K, Lüthi JC, Taffé P, et al. Impact of an interdisciplinary strategy on antibiotic use: a prospective controlled study in three hospitals. J Antimicrobial Chemother. 2005;55(3):362–6.CrossRef
17.
go back to reference Apisarnthanarak A, Danchaivijitr S, Khawcharoenporn T, Limsrivilai J, Warachan B, Bailey TC, et al. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis. 2006;42(6):768–75.PubMedCrossRef Apisarnthanarak A, Danchaivijitr S, Khawcharoenporn T, Limsrivilai J, Warachan B, Bailey TC, et al. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis. 2006;42(6):768–75.PubMedCrossRef
18.
go back to reference Mach R, Vlcek J, Prusova M, Batka P, Rysavy V, Kubena A. Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech Hospital. Pharm World Sci. 2007;29(5):565–72.PubMedCrossRef Mach R, Vlcek J, Prusova M, Batka P, Rysavy V, Kubena A. Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech Hospital. Pharm World Sci. 2007;29(5):565–72.PubMedCrossRef
Metadata
Title
Effects of an operational multidisciplinary team on hospital antibiotic use and cost in France: a cluster controlled trial
Authors
Sibylle Bevilacqua
Béatrice Demoré
Marie-Line Erpelding
Emmanuelle Boschetti
Thierry May
Isabelle May
Christian Rabaud
Nathalie Thilly
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2011
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9499-9

Other articles of this Issue 3/2011

International Journal of Clinical Pharmacy 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.